• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ON-X LIFE TECHNOLOGIES, INC. ONX ASCENDING AORTIC 25; HEART-VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ON-X LIFE TECHNOLOGIES, INC. ONX ASCENDING AORTIC 25; HEART-VALVE, MECHANICAL Back to Search Results
Model Number ONXAAP-25
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 04/04/2019
Event Type  Injury  
Manufacturer Narrative
This investigation is currently on going.Any additional information will be provided in the follow-up report.This report is being submitted as required by regulations and does not constitute an admission that the device caused or contributed to the reported event.Furthermore, this report reflects the event as alleged by the complainant and does not imply that the information reported to artivion is accurate or has been confirmed by artivion.
 
Event Description
According to the initial report received, "patient is subject#: (b)(6) in the post-market clinical follow-up study protocol of the on-x ascending aortic prosthesis (aap) retrospective study and was implanted on (b)(6) 2011 with a surgeon made aap device and on-x aortic valve sn#: (b)(6).On (b)(6) 2019 (2941 days post implant) presented to the ed with a complaint of sudden onset of confusion and expressive aphasia.He was admitted for observation and a ct was completed, showing no acute hemorrhage and a small hypoattenuating focus in the left basal ganglia which is new since previous ct but is age-indeterminate.Inr was 2.4 at time of admission.Patient had resolution of symptoms within a few hours and was back to baseline at time of discharge home on (b)(6) 2019.Admitting diagnosis: transient episode of global aphasia.".
 
Event Description
According to the initial report received, "patient is subject (b)(6) in the post-market clinical follow-up study protocol of the on-x ascending aortic prosthesis (aap) retrospective study and was implanted on (b)(6) 2011 with a surgeon made aap device and on-x aortic valve sn (b)(6).On (b)(6) 2019 (2941 days post implant) presented to the ed with a complaint of sudden onset of confusion and expressive aphasia.He was admitted for observation and a ct was completed, showing no acute hemorrhage and a small hypoattenuating focus in the left basal ganglia which is new since previous ct but is age-indeterminate.Inr was 2.4 at time of admission.Patient had resolution of symptoms within a few hours and was back to baseline at time of discharge home on (b)(6) 2019.Admitting diagnosis : transient episode of global aphasia." this investigation is relegated to onxaap-25, sn (b)(6) (manufacturing date 01nov2009).Receipt of the adjudication form deemed the event not valve related.Per (b)(4) a complaint is ¿written, electronic or oral communication that alleges deficiencies related to the identity, quality, durability, reliability, usability, safety or performance of a medical device that has been released from the organization¿s control or related to a service that affects the performance of such medical devices.¿ based on the information provided to artivion, there is no allegation of deficiency or resultant adverse event cause by the artivion product; therefore, further investigation is not warranted.
 
Manufacturer Narrative
Receipt of the adjudication form deemed the event not valve related.This report is being submitted as required by federal regulations and does not constitute an admission that the device caused or contributed to the reported event.Furthermore, this report reflects the event as alleged by the complainant and does not imply that the information reported to artivion is accurate or has been confirmed by artivion.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ONX ASCENDING AORTIC 25
Type of Device
HEART-VALVE, MECHANICAL
Manufacturer (Section D)
ON-X LIFE TECHNOLOGIES, INC.
1300 east anderson lane
austin TX 78752
Manufacturer (Section G)
ON-X LIFE TECHNOLOGIES, INC.
1300 east anderson lane
austin TX 78752
Manufacturer Contact
rochelle maney
1655 roberts blvd.
kennesaw, GA 30144
7704193355
MDR Report Key18591786
MDR Text Key333894624
Report Number1649833-2024-00008
Device Sequence Number1
Product Code LWQ
UDI-Device Identifier00851788001532
UDI-Public00851788001532
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 02/02/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/26/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Model NumberONXAAP-25
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received01/19/2024
Date Device Manufactured11/01/2009
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
Patient Age70 YR
Patient SexPrefer Not To Disclose
-
-